Labviva vs Tempus

Side-by-side comparison of AI visibility scores, market position, and capabilities

Tempus leads in AI visibility (74 vs 36)
Labviva logo

Labviva

NicheLife Sciences & BioTech

Life Sciences Procurement Marketplace

Labviva is a digital procurement marketplace for life sciences researchers, connecting labs at academic institutions and biopharma companies with scientific suppliers; raised $22M Series A in 2022;

AI VisibilityBeta
Overall Score
D36
Category Rank
#84 of 198
AI Consensus
86%
Trend
stable
Per Platform
ChatGPT
34
Perplexity
38
Gemini
35

About

Labviva is a Boston-based life sciences technology company founded in 2017 by Lina Nilsson and Barry Bettman. It operates a digital procurement marketplace purpose-built for scientific researchers at pharmaceutical companies, biotech firms, academic research institutions, and hospitals. The platform aggregates product catalogs from thousands of scientific suppliers — including reagents, lab equipment, consumables, and biological materials — into a unified, searchable interface that integrates directly with institutional procurement and ERP systems such as SAP, Coupa, and Jaggaer. This eliminates the fragmented, email-and-catalog-driven purchasing workflows that dominate scientific procurement.

Full profile
Tempus logo

Tempus

LeaderLife Sciences & BioTech

AI-Enabled Precision Medicine

Publicly traded AI precision medicine company (Nasdaq: TEM); $1.27B revenue in 2025 (+83% YoY); $14B+ market cap; genomic profiling, algorithmic diagnostics, and clinical trial matching across oncology, neurology, and cardiology.

AI VisibilityBeta
Overall Score
B74
Category Rank
#11 of 198
AI Consensus
68%
Trend
stable
Per Platform
ChatGPT
71
Perplexity
68
Gemini
80

About

Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder of Groupon) and headquartered in Chicago, Illinois, Tempus built the world's largest library of clinical and molecular data and applies AI to help physicians make more personalized, data-driven treatment decisions. The company's core offerings include genomic profiling (sequencing tumor DNA to identify mutations and actionable targets), algorithmic diagnostic tests (AI-driven companion diagnostics for cancer treatment selection), clinical trial matching (connecting eligible patients to appropriate studies), and data licensing to pharmaceutical and biotech partners for drug discovery and clinical development.

Full profile

AI Visibility Head-to-Head

36
Overall Score
74
#84
Category Rank
#11
86
AI Consensus
68
stable
Trend
stable
34
ChatGPT
71
38
Perplexity
68
35
Gemini
80
33
Claude
77
32
Grok
69

Key Details

Category
Life Sciences Procurement Marketplace
AI-Enabled Precision Medicine
Tier
Niche
Leader
Entity Type
brand
brand

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.